Search Within

Maria Lia Palomba

Formats
  1. Meeting Abstract (289)
  2. Journal Article (131)
  3. Research Letter (10)
  4. Review (8)
  5. Correspondence (4)
  6. Editorial (3)
  7. Book Section (1)
  8. Conference Paper (1)
  9. Guidelines (1)
Groups
  1. Center for Hematologic Malignancies (448)
  2. Department of Medicine (448)
  3. Hematologic Malignancies, Division of (448)
  4. Lymphoma (448)
  5. Hematology-Oncology Fellows (228)
  6. Survivorship Research (209)

More Groups

People
  1. Andrew Zelenetz (143)
  2. Ariela Noy (132)
  3. Paul Hamlin (126)
  4. Gilles Salles (114)
  5. Steven Horwitz (112)
  6. Gunjan Shah (111)

More People

Years
  1. 2025 (19)
  2. 2024 (58)
  3. 2023 (69)
  4. 2022 (39)
  5. 2021 (41)
  6. 2020 (43)

More Years

Publications
  1. Blood (187)
  2. Journal of Clinical Oncology (37)
  3. Hematological Oncology (30)
  4. Blood Advances (19)
  5. Blood Cancer Journal (15)
  6. British Journal of Haematology (14)

More Publications

Publishers
  1. American Society of Hematology (207)
  2. Elsevier Inc. (45)
  3. American Society of Clinical Oncology (38)
  4. Nature Publishing Group (33)
  5. Wiley Blackwell (31)
  6. John Wiley & Sons (14)

More Publishers

Results (448)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genomic profiling of mantle cell lymphoma suggests poor-risk profile is present at diagnosis and does not arise by tumor evolution
    Meeting Abstract

    Joffe, E.; Kumar, A.; Zheng, S.; Uppal, M.; Bantilan, K. S.; Atteberry, P.; Straus, D. J.; Palomba, M. L.; Noy, A.; Horwitz, S. M.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Chimeric antigen receptor T-cell therapies for aggressive B-cell lymphomas: Current and future state of the art
    Review

    Abramson, J. S.; Lunning, M.; Palomba, M. L.
    American Society of Clinical Oncology Educational Book (2019)

    Fulltext@MSK | Save
  • Patient-reported outcomes from patients with Waldenstrom macroglobulinemia treated with ibrutinib-rituximab: Results from iNNOVATE study
    Meeting Abstract

    Matous, J. V.; Tedeschi, A.; Dimopoulos, M. A.; Trotman, J.; Garcia-Sanz, R.; Macdonald, D.; Mahe, B.; Herbaux, C.; Heffner, L.; Tam, C. S.; more...
    American Journal of Hematology (2019)

    Fulltext@MSK | Save
  • Safety and preliminary efficacy in patients (pts) with relapsed/refractory (R/R) mantle cell lymphoma (MCL) receiving lisocabtagene maraleucel (Liso-cel) in TRANSCEND NHL 001
    Meeting Abstract

    Wang, M.; Gordon, L. I.; Palomba, M. L.; Abramson, J. S.; Andreadis, C.; Ghosh, N.; Lunning, M. A.; Maloney, D. G.; Farazi, T. A.; Garcia, J.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Patient-reported outcomes (PROs) with ibrutinib-rituximab in Waldenstrom macroglobulinemia (WM): Results from iNNOVATE
    Meeting Abstract

    Tedeschi, A.; Dimopoulos, M. A.; Trotman, J.; Garcia-Sanz, R.; MacDonald, D.; Mahe, B.; Herbaux, C.; Heffner, L. T.; Tam, C. S. L.; Varettoni, M.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Lisocabtagene maraleucel (liso-cel) treatment of patients (pts) with relapsed/refractory (R/R) B-cell non-Hodgkin lymphoma (NHL) and secondary CNS lymphoma: Initial results from TRANSCEND NHL 001
    Meeting Abstract

    Abramson, J. S.; Palomba, M. L.; Arnason, J. E.; Lunning, M. A.; Solomon, S. R.; Farazi, T.; Garcia, J.; Xie, B.; Newhall, K. J.; Dehner, C.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Safety and feasibility of chimeric antigen receptor T cell therapy after allogeneic hematopoietic cell transplantation in relapsed/refractory B cell non-Hodgkin lymphoma
    Journal Article

    Jain, T.; Sauter, C. S.; Shah, G. L.; Maloy, M. A.; Chan, J.; Scordo, M.; Avecilla, S. T.; Batlevi, Y.; Dahi, P. B.; Batlevi, C. W.; more...
    Leukemia (2019)

    Fulltext@MSK | Save
  • Resource utilization within 30 days of car T cells for hematologic malignancies
    Meeting Abstract

    Shah, G.; Park, J.; Sauter, C.; Duck, E.; Halton, E.; Batlevi, C.; Palomba, M. L.; Younes, A.; Geyer, M.; Smith, E.; more...
    Value in Health (2019)

    Fulltext@MSK | Save
  • Constitutive activation of the B cell receptor underlies dysfunctional signaling in chronic lymphocytic leukemia
    Journal Article

    Ziegler, C. G. K.; Kim, J.; Piersanti, K.; Oyler-Yaniv, A.; Argyropoulos, K. V.; van den Brink, M. R. M.; Palomba, M. L.; Altan-Bonnet, N.; Altan-Bonnet, G.
    Cell Reports (2019)

    Fulltext@MSK | Save
  • Safety and clinical activity of atezolizumab in combination with tazemetostat in relapsed or refractory diffuse large B-cell lymphoma: Primary analysis of a phase 1B study
    Meeting Abstract

    Palomba, M. L.; Cartron, G.; Popplewell, L.; Ribrag, V.; Westin, J.; Chitra, S.; Huw, L.; Newberry, K.; Raval, A.; Xu, J.; more...
    Hematological Oncology (2019)

    Fulltext@MSK | Save